| Product Code: ETC12732933 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neoantigen Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 China Neoantigen Market - Industry Life Cycle |
3.4 China Neoantigen Market - Porter's Five Forces |
3.5 China Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 China Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development of neoantigen therapies in China |
4.2.2 Growing prevalence of cancer cases in China, driving the demand for innovative treatment options like neoantigen therapies |
4.2.3 Supportive government policies and initiatives to boost the biotechnology and healthcare sectors in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neoantigen therapies in China |
4.3.2 Limited awareness and understanding of neoantigen therapies among healthcare providers and patients in China |
5 China Neoantigen Market Trends |
6 China Neoantigen Market, By Types |
6.1 China Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 China Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 China Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 China Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 China Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 China Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 China Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 China Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 China Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 China Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 China Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 China Neoantigen Market Import-Export Trade Statistics |
7.1 China Neoantigen Market Export to Major Countries |
7.2 China Neoantigen Market Imports from Major Countries |
8 China Neoantigen Market Key Performance Indicators |
8.1 Number of clinical trials for neoantigen therapies conducted in China |
8.2 Funding raised by biotech companies in China specifically for neoantigen research and development |
8.3 Adoption rate of neoantigen therapies in major hospitals and cancer treatment centers in China. |
9 China Neoantigen Market - Opportunity Assessment |
9.1 China Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 China Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Neoantigen Market - Competitive Landscape |
10.1 China Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 China Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here